[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"type-2-diabetes-mellitus-t2dm-cost-effectiveness-sulfonylureas-dpp4-inhibitors-metformin\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:type-2-diabetes-mellitus-t2dm-cost-effectiveness-sulfonylureas-dpp4-inhibitors-metformin":23},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":4,"overallStatus":24,"whyStopped":4,"lastUpdateSubmitDate":25,"lastUpdatePostDateStruct":26,"startDateStruct":29,"completionDateStruct":31,"leadSponsor":33,"locationsCount":5},"100559964","comparative-analysis-of-cost-effectiveness-between-sulfonylureas-and-dpp4-inhibitors-in-combination-with-metformin-in-treatment-of-type-2-diabetic-patients--a-retrospective-observational-study-100559964",false,"NCT06570980","Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.","Inclusion Criteria:\n\n* New onset type2 diabetes mellitus diagnosed for 2 -5 years.\n* Taking either sulfonylurea or DPP4 inhibitors combined with Metformin from the time of diagnosis.\n* Age 18 years or above.\n* Both male and female.\n* Provided written informed consent.\n\nExclusion Criteria:\n\n* Unwillingness to participate or unwillingness to give written informed consent.\n* Patients on Insulin therapy or monotherapy with metformin since the time of diagnosis.\n* Taking other than sulfonylurea or DPP4 inhibitors combined with Metformin from the time of diagnosis.\n* Diabetes related complications at the time of diagnosis.","ALL","18 Years",{"count":18,"type":19},200,"ESTIMATED","OBSERVATIONAL","The aim of this study is to compare the cost effectiveness of Sulfonylureas and DPP4-inhibitors in combination with Metformin among type2 diabetic patients diagnosed for 2-5 years. Glycemic status and other clinical outcome are compared in between two groups and ICER are compared.",[23],"Type 2 Diabetes Mellitus (T2DM), Cost-effectiveness, Sulfonylureas, DPP4 Inhibitors, Metformin","RECRUITING","2024-08-22",{"date":27,"type":28},"2024-08-26","ACTUAL",{"date":30,"type":28},"2023-08-25",{"date":32,"type":19},"2024-08-30",{"name":34,"class":35},"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","OTHER"]